Cargando…

Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19

This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianwei, Ma, Yunbiao, Shi, Beibei, Yang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826234/
https://www.ncbi.nlm.nih.gov/pubmed/35155358
http://dx.doi.org/10.3389/fpubh.2021.812253
_version_ 1784647389907255296
author Li, Jianwei
Ma, Yunbiao
Shi, Beibei
Yang, Yi
author_facet Li, Jianwei
Ma, Yunbiao
Shi, Beibei
Yang, Yi
author_sort Li, Jianwei
collection PubMed
description This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise are found to be more valuable, that is, the stock price of non-state-owned enterprises are more immune to the negative shocks of COVID-19. For board structure, the arrangement of the duality of chairman and CEO is found to be more valuable and can effectively alleviate the negative shocks of the epidemic on the stock price. For managerial incentives mechanisms, it shows that management shareholding, management compensation, and executive stock options are all effective mechanisms and can better withstand the negative shocks of the COVID-19 epidemic on the stock price of companies. This paper sheds light on the value of corporate governance mechanisms in the Chinese capital market from the perspective of investors, which enriches literature in the field of corporate governance.
format Online
Article
Text
id pubmed-8826234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88262342022-02-10 Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19 Li, Jianwei Ma, Yunbiao Shi, Beibei Yang, Yi Front Public Health Public Health This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise are found to be more valuable, that is, the stock price of non-state-owned enterprises are more immune to the negative shocks of COVID-19. For board structure, the arrangement of the duality of chairman and CEO is found to be more valuable and can effectively alleviate the negative shocks of the epidemic on the stock price. For managerial incentives mechanisms, it shows that management shareholding, management compensation, and executive stock options are all effective mechanisms and can better withstand the negative shocks of the COVID-19 epidemic on the stock price of companies. This paper sheds light on the value of corporate governance mechanisms in the Chinese capital market from the perspective of investors, which enriches literature in the field of corporate governance. Frontiers Media S.A. 2022-01-26 /pmc/articles/PMC8826234/ /pubmed/35155358 http://dx.doi.org/10.3389/fpubh.2021.812253 Text en Copyright © 2022 Li, Ma, Shi and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Li, Jianwei
Ma, Yunbiao
Shi, Beibei
Yang, Yi
Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
title Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
title_full Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
title_fullStr Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
title_full_unstemmed Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
title_short Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
title_sort can the market recognize the value of the corporate governance mechanism of chinese listed companies?—empirical evidence from covid-19
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826234/
https://www.ncbi.nlm.nih.gov/pubmed/35155358
http://dx.doi.org/10.3389/fpubh.2021.812253
work_keys_str_mv AT lijianwei canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19
AT mayunbiao canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19
AT shibeibei canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19
AT yangyi canthemarketrecognizethevalueofthecorporategovernancemechanismofchineselistedcompaniesempiricalevidencefromcovid19